Jacobiopharma Details
Aug 30, 2018

Jacobio successfully completes Series C financing

Garcos has announced the successful completion of its $ 55 million Series C financing. This round of financing was jointly led by Qiming Venture Capital and Gao Capital, and Fangyuan Fund followed suit. Previously, Qiming Venture Capital also participated in the B round of financing led by Lilly Asia Fund in 2017. The funds raised will be used for JAB-3000 Sino-US clinical research and pre-clinical research on other projects to enrich the research and development pipeline.

Source: Jacobiopharma